Big Blues May Benefit From Tentative Antitrust Settlement

The Blue Cross and Blue Shield Association (BCBSA) has reportedly reached a tentative settlement in a lengthy legal battle over whether its member plans engage in anticompetitive business practices. And although it may seem like a counterintuitive result for an antitrust lawsuit, the settlement’s terms will likely give Blues plans more freedom to collaborate and consolidate, industry analysts say.

The lawsuit in question was filed in 2012 on behalf of employers and policyholders who took issue with Blues plans’ agreement to divide the country among the association’s 36 members and to restrict members’ ability to offer non-Blues products. A related lawsuit filed by health care providers, which was then consolidated with the employer/policyholder lawsuit, alleged that the Blues’ anticompetitive practices improperly depressed their reimbursement. In 2018, a federal judge delivered a boost to the plaintiffs’ case by deciding that the burden of proof falls on BCBSA to prove its practices are not anticompetitive (HPW 5/7/18, p. 9) — a decision that held up on appeal later that year.

0 Comments
© 2024 MMIT
Leslie Small

Leslie Small

Leslie has been working in journalism since 2009 and reporting on the health care industry since 2014. She has covered the many ups and downs of the Affordable Care Act exchanges, the failed health insurer mega-mergers, and hundreds of other storylines spanning subjects such as Medicaid managed care, Medicare Advantage, employer-sponsored insurance, and prescription drug coverage. As the managing editor of Health Plan Weekly and Radar on Drug Benefits, she writes and edits for both publications while overseeing a small team of reporters who also focus on the managed care sector. Before joining AIS Health, she was a senior editor for the e-newsletter Fierce Health Payer, and she started her career as a copy editor at multiple local newspapers. She graduated with a dual degree in journalism and political science from Penn State University.

Related Posts

needle-and-bills
September 6

Health Care Utilization Outpaces Pre-Pandemic Levels in Early 2024

READ MORE
happy-guys-on-computer
September 6

CareFirst’s Involvement in Startup Accelerator Shows its Intrigue With AI

READ MORE
cigna-on-laptop
September 6

Cigna CEO Offers Medical Cost Update, Touts Stelara Biosimilar

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today